These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1790720)

  • 41. Ofloxacin concentrations in tissues involved in respiratory tract infections.
    Perea EJ
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease.
    Kontou P; Chatzika K; Pitsiou G; Stanopoulos I; Argyropoulou-Pataka P; Kioumis I
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4149-53. PubMed ID: 21670178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleural penetration of ciprofloxacin in patients with empyema thoracis.
    Morgenroth A; Pfeuffer HP; Seelmann R; Schweisfurth H
    Chest; 1991 Aug; 100(2):406-9. PubMed ID: 1864115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg.
    Naber KG; Sörgel F; Kinzig M; Weigel DM
    J Urol; 1993 Nov; 150(5 Pt 2):1718-21. PubMed ID: 8411457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extravascular penetration of ciprofloxacin. A review.
    Bergan T
    Diagn Microbiol Infect Dis; 1990; 13(2):103-14. PubMed ID: 2196148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
    Hollenstein UM; Brunner M; Schmid R; Müller M
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Zingiber officinale on the plasma pharmacokinetics and lung penetrations of ciprofloxacin and isoniazid.
    Nduka SO; Okonta MJ; Esimone CO
    Am J Ther; 2013; 20(5):507-13. PubMed ID: 23344089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Penetration of fleroxacin into body tissues and fluids.
    Weidekamm E; Portmann R
    Am J Med; 1993 Mar; 94(3A):75S-80S. PubMed ID: 8452186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
    Stass H; Delesen H; Nagelschmitz J; Staab D
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of orally administered prulifloxacin into human lung tissue.
    Concia E; Allegranzi B; Ciottoli GB; Orticelli G; Marchetti M; Dionisio P
    Clin Pharmacokinet; 2005; 44(12):1287-94. PubMed ID: 16372826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penetration and concentration of cefadroxil in sputum, lung and pleural fluid.
    Nightingale CH
    Drugs; 1986; 32 Suppl 3():17-20. PubMed ID: 3803249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
    Kees F; Naber KG; Schumacher H; Grobecker H
    Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro biopharmaceutical evaluation of ciprofloxacin/metal cation complexes for pulmonary administration.
    Brillault J; Tewes F; Couet W; Olivier JC
    Eur J Pharm Sci; 2017 Jan; 97():92-98. PubMed ID: 27863308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
    Le Gros V; Farinotti R; Brion N; Regnard JF; Azorin J; Parrot AM; Chiche D
    Pathol Biol (Paris); 1992 May; 40(5):545-50. PubMed ID: 1495842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
    Dhalluin-Venier V; Bazin C; Massias L; Farah RB; Boytchev I; Fritsch J; Choury AD; Prat F; Buffet C; Furlan V; Pelletier G
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):127-30. PubMed ID: 18188033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of the distribution of oral ciprofloxacin into the mucosa of the middle ear and the cortical bone of the mastoid process.
    Massias L; Buffe P; Cohen B; Cudennec Y; Gehanno P; Sterkers O; Farinotti R
    Chemotherapy; 1994; 40 Suppl 1():3-7. PubMed ID: 7805429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations.
    Breilh D; Saux MC; Maire P; Vergnaud JM; Jelliffe RW
    Comput Biol Med; 2001 May; 31(3):147-55. PubMed ID: 11173053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bronchopulmonary penetration of ciprofloxacin].
    Loos U; Marklein G; Scholl H; Schwabe HK
    Pneumologie; 1990 Feb; 44 Suppl 1():312-3. PubMed ID: 2367402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.